Human papillomaviruses-related cancers Presence and prevention strategies in the Middle East and North African Regions

Human Vaccines and Immunotherapeutics

Volumn 10, Issue 7, 2014, Pages 1812-1821

  Al Moustafa, Ala Eddin ^a,b,c,d   Al Awadhi, Rana ^e   Missaoui, Nabiha ^f   Adam, Ishag ^g   Durusoy, Raika ^h   Ghabreau, Lina ^d,i   Akil, Nizar ^d,i   Gadelkarim Ahmed, Hussain ^j   Yasmeen, Amber ^b   Alsbeih, Ghazi ^k  

^a Research and Development Center   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c Dept of Electrical and Computer Engineering   (Canada)

^d Syrian Society Against Cancer   (Syrian Arab Republic)

^e KUWAIT UNIVERSITY   (Kuwait)

^f Cancer Epidemiology and Cytopathology in Tunisian Center   (Tunisia)

^g UNIVERSITY OF KHARTOUM   (Sudan)

^h EGE UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

ⁱ UNIVERSITY OF ALEPPO   (Syrian Arab Republic)

^j UNIVERSITY OF HAIL   (Saudi Arabia)

^k KING FAISAL SPECIALIST HOSPITAL AND RESEARCH CENTER   (Saudi Arabia)

more..

Author keywords

HPVs; HPVs cancers; Middle East; North africa; Vaccination

Indexed keywords

APOLIPOPROTEIN E5; PROTEIN E6; PROTEIN E7; WART VIRUS VACCINE;

APOPTOSIS; BREAST CANCER; CANCER GROWTH; CARCINOGENESIS; CELL PROLIFERATION; COLORECTAL CANCER; DISEASE ASSOCIATION; HEAD AND NECK CANCER; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; INCIDENCE; MALIGNANT NEOPLASTIC DISEASE; MIDDLE EAST; NORTH AFRICA; PAPILLOMAVIRUS INFECTION; PREVALENCE; PROTEIN FUNCTION; REVIEW; UTERINE CERVIX CANCER; VACCINATION; AFRICA; BREAST NEOPLASMS; CLASSIFICATION; COLORECTAL NEOPLASMS; COMPLICATION; FEMALE; HEAD AND NECK NEOPLASMS; IMMUNOLOGY; ISOLATION AND PURIFICATION; PAPILLOMAVIRIDAE; UTERINE CERVICAL NEOPLASMS; VIROLOGY;

AFRICA, NORTHERN; BREAST NEOPLASMS; COLORECTAL NEOPLASMS; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; MIDDLE EAST; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PAPILLOMAVIRUS VACCINES; UTERINE CERVICAL NEOPLASMS;

EID: 84908383958     PISSN: 21645515     EISSN: 2164554X     Source Type: Journal    
DOI: 10.4161/hv.28742     Document Type: Review

References (152)

1. Zhang X, Zhang Z, Zheng B, He Z, Winberg G, Ernberg I. An update on viral association of human cancers. Arch Virol 2013; 158:1433-43; PMID:23417394; http://dx.doi.org/10.1007/s00705-013-1623-9
2. Zheng ZM. Viral oncogenes, noncoding RNAs, and RNA splicing in human tumor viruses. Int J Biol Sci 2010; 6:730-55; PMID:21152115; http://dx.doi.org/10.7150/ijbs.6.730
3. Smith JS, Lindsay L, Hoots B, Keys J, Franceschi S, Winer R, Clifford GM. Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical lesions: a meta-analysis update. Int J Cancer 2007; 121:621-32; PMID:17405118; http://dx.doi.org/10.1002/ijc.22527
4. Stanley MA. Genital human papillomavirus infections: current and prospective therapies. J Gen Virol 2012; 93:681-91; PMID:22323530; http://dx.doi.org/10.1099/vir.0.039677-0
5. Al Moustafa A-E. Role of High-Risk Human Papillomaviruses in Breast Carcinogenesis; Oncoviruses and Their Inhibitors; Editor: Satya P. Gupta; Publishers: CRC Press, Taylor and Francis Group, Boca Raton, USA; ISBN: Not yet assigned.
6. de Villiers EM, Fauquet C, Broker TR, Bernard HU, zur Hausen H. Classification of papillomaviruses. Virology 2004; 324:17-27; PMID:15183049; http://dx.doi.org/10.1016/j.virol.2004.03.033
7. Bernard HU. The clinical importance of the nomenclature, evolution and taxonomy of human papillomaviruses. J Clin Virol 2005; 32(Suppl 1):S1-6; PMID:15753006; http://dx.doi.org/10.1016/j.jcv.2004.10.021
8. Castellsagué X, Díaz M, de Sanjosé S, Muñoz N, Herrero R, Franceschi S, Peeling RW, Ashley R, Smith JS, Snijders PJ, et al.; International Agency for Research on Cancer Multicenter Cervical Cancer Study Group. Worldwide human papillomavirus etiology of cervical adenocarcinoma and its cofactors: implications for screening and prevention. J Natl Cancer Inst 2006; 98:303-15; PMID:16507827; http://dx.doi.org/10.1093/jnci/djj067
9. Schwartz SM, Daling JR, Shera KA, Madeleine MM, McKnight B, Galloway DA, Porter PL, McDougall JK. Human papillomavirus and prognosis of invasive cervical cancer: a population-based study. J Clin Oncol 2001; 19:1906-15; PMID:11283122
10. Clifford GM, Smith JS, Plummer M, Muñoz N, Franceschi S. Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis. Br J Cancer 2003; 88:63-73; PMID:12556961; http://dx.doi.org/10.1038/sj.bjc.6600688
11. Al Moustafa AE, Foulkes WD, Benlimame N, Wong A, Yen L, Bergeron J, Batist G, Alpert L, Alaoui-Jamali MA. E6/E7 proteins of HPV type 16 and ErbB-2 cooperate to induce neoplastic transformation of primary normal oral epithelial cells. Oncogene 2004; 23:350-8; PMID:14724563; http://dx.doi.org/10.1038/sj.onc.1207148
12. Al Moustafa AE, Kassab A, Darnel A, Yasmeen A. High-risk HPV/ErbB-2 interaction on E-cadherin/catenin regulation in human carcinogenesis. Curr Pharm Des 2008; 14:2159-72; PMID:18781969; http://dx.doi.org/10.2174/138161208785740216
13. Venuti A, Badaracco G, Rizzo C, Mafera B, Rahimi S, Vigili M. Presence of HPV in head and neck tumours: high prevalence in tonsillar localization. J Exp Clin Cancer Res 2004; 23:561-6; PMID:15743024
14. Daling JR, Madeleine MM, Johnson LG, Schwartz SM, Shera KA, Wurscher MA, Carter JJ, Porter PL, Galloway DA, McDougall JK. Human papillomavirus, smoking, and sexual practices in the etiology of anal cancer. Cancer 2004; 101:270-80; PMID:15241823; http://dx.doi.org/10.1002/cncr.20365
15. Ragin CC, Taioli E. Survival of squamous cell carcinoma of the head and neck in relation to human papillomavirus infection: review and meta-analysis. Int J Cancer 2007; 121:1813-20; PMID:17546592; http://dx.doi.org/10.1002/ijc.22851
16. Graflund M, Sorbe B, Sigurdardóttir S, Karlsson M. HPV-DNA, vascular space invasion, and their impact on the clinical outcome in early-stage cervical carcinomas. Int J Gynecol Cancer 2004; 14:896-902; PMID:15361201; http://dx.doi.org/10.1111/j.1048-891X.2004.014527.x
17. Zuna RE, Allen RA, Moore WE, Mattu R, Dunn ST. Comparison of human papillomavirus genotypes in high-grade squamous intraepithelial lesions and invasive cervical carcinoma: evidence for differences in biologic potential of precursor lesions. Mod Pathol 2004; 17:1314-22; PMID:15257311; http://dx.doi.org/10.1038/modpathol.3800223
18. Begum S, Gillison ML, Ansari-Lari MA, Shah K, Westra WH. Detection of human papillomavirus in cervical lymph nodes: a highly effective strategy for localizing site of tumor origin. Clin Cancer Res 2003; 9:6469-75; PMID:14695150
19. Umudum H, Rezanko T, Dag F, Dogruluk T. Human papillomavirus genome detection by in situ hybridization in fine-needle aspirates of metastatic lesions from head and neck squamous cell carcinomas. Cancer 2005; 105:171-7; PMID:15822131; http://dx.doi.org/10.1002/cncr.21027
20. Varnai AD, Bollmann M, Griefingholt H, Speich N, Schmitt C, Bollmann R, Decker D. HPV in anal squamous cell carcinoma and anal intraepithelial neoplasia (AIN). Impact of HPV analysis of anal lesions on diagnosis and prognosis. Int J Colorectal Dis 2006; 21:135-42; PMID:15864603; http://dx.doi.org/10.1007/s00384-005-0777-7
21. Liu Y, Klimberg VS, Andrews NR, Hicks CR, Peng H, Chiriva-Internati M, Henry-Tillman R, Hermonat PL. Human papillomavirus DNA is present in a subset of unselected breast cancers. J Hum Virol 2001; 4:329-34; PMID:12082399
22. Kan CY, Iacopetta BJ, Lawson JS, Whitaker NJ. Identification of human papillomavirus DNA gene sequences in human breast cancer. Br J Cancer 2005; 93:946-8; PMID:16222323; http://dx.doi.org/10.1038/sj.bjc.6602778
23. de Villiers EM, Sandstrom RE, zur Hausen H, Buck CE. Presence of papillomavirus sequences in condylomatous lesions of the mamillae and in invasive carcinoma of the breast. Breast Cancer Res 2005; 7:R1-11; PMID:15642157; http://dx.doi.org/10.1186/bcr940
24. Akil N, Yasmeen A, Kassab A, Ghabreau L, Darnel AD, Al Moustafa AE. High-risk human papillomavirus infections in breast cancer in Syrian women and their association with Id-1 expression: a tissue microarray study. Br J Cancer 2008; 99:404-7; PMID:18648363; http://dx.doi.org/10.1038/sj.bjc.6604503
25. Antonsson A, Spurr TP, Chen AC, Francis GD, McMillan NA, Saunders NA, Law M, Bennett IC. High prevalence of human papillomaviruses in fresh frozen breast cancer samples. J Med Virol 2011; 83:2157-63; PMID:22012724; http://dx.doi.org/10.1002/jmv.22223
26. Glenn WK, Heng B, Delprado W, Iacopetta B, Whitaker NJ, Lawson JS. Epstein-Barr virus, human papillomavirus and mouse mammary tumour virus as multiple viruses in breast cancer. PLoS One 2012; 7:e48788; PMID:23183846; http://dx.doi.org/10.1371/journal.pone.0048788
27. Gopalkrishna V, Singh UR, Sodhani P, Sharma JK, Hedau ST, Mandal AK, Das BC. Absence of human papillomavirus DNA in breast cancer as revealed by polymerase chain reaction. Breast Cancer Res Treat 1996; 39:197-202; PMID:8872328; http://dx.doi.org/10.1007/BF01806186
28. Lindel K, Forster A, Altermatt HJ, Greiner R, Gruber G. Breast cancer and human papillomavirus (HPV) infection: no evidence of a viral etiology in a group of Swiss women. Breast 2007; 16:172-7; PMID:17088061; http://dx.doi.org/10.1016/j.breast.2006.09.001
29. Hachana M, Ziadi S, Amara K, Toumi I, Korbi S, Trimeche M. No evidence of human papillomavirus DNA in breast carcinoma in Tunisian patients. Breast 2010; 19:541-4; PMID:20547456; http://dx.doi.org/10.1016/j.breast.2010.05.007
30. Seoud M. Burden of human papillomavirus-related cervical disease in the extended middle East and north Africa-a comprehensive literature review. J Low Genit Tract Dis 2012; 16:106-20; PMID:22371041; http://dx.doi.org/10.1097/LGT.0b013e31823a0108
31. The Greater Middle East. http://en.wikipedia.org/wiki/Greater-Middle-East
32. Motoyama S, Ladines-Llave CA, Luis Villanueva S, Maruo T. The role of human papilloma virus in the molecular biology of cervical carcinogenesis. Kobe J Med Sci 2004; 50:9-19; PMID:15342967
33. Longworth MS, Laimins LA. The binding of histone deacetylases and the integrity of zinc finger-like motifs of the E7 protein are essential for the life cycle of human papillomavirus type 31. J Virol 2004; 78:3533-41; PMID:15016876; http://dx.doi.org/10.1128/JVI.78.7.3533-3541.2004
34. Doorbar J. The papillomavirus life cycle. J Clin Virol 2005; 32(Suppl 1):S7-15; PMID:15753007; http://dx.doi.org/10.1016/j.jcv.2004.12.006
35. Moody CA, Laimins LA. Human papillomaviruses activate the ATM DNA damage pathway for viral genome amplification upon differentiation. PLoS Pathog 2009; 5:e1000605; PMID:19798429; http://dx.doi.org/10.1371/journal.ppat.1000605
36. Grm HS, Massimi P, Gammoh N, Banks L. Crosstalk between the human papillomavirus E2 transcriptional activator and the E6 oncoprotein. Oncogene 2005; 24:5149-64; PMID:15856010; http://dx.doi.org/10.1038/sj.onc.1208701
37. Yuan CH, Filippova M, Duerksen-Hughes P. Modulation of apoptotic pathways by human papillomaviruses (HPV): mechanisms and implications for therapy. Viruses 2012; 4:3831-50; PMID:23250450; http://dx.doi.org/10.3390/v4123831
38. Kim SH, Juhnn YS, Kang S, Park SW, Sung MW, Bang YJ, Song YS. Human papillomavirus 16 E5 up-regulates the expression of vascular endothelial growth factor through the activation of epidermal growth factor receptor, MEK/ ERK1,2 and PI3K/Akt. Cell Mol Life Sci 2006; 63:930-8; PMID:16596339; http://dx.doi.org/10.1007/s00018-005-5561-x
39. Suprynowicz FA, Disbrow GL, Krawczyk E, Simic V, Lantzky K, Schlegel R. HPV-16 E5 oncoprotein upregulates lipid raft components caveolin-1 and ganglioside GM1 at the plasma membrane of cervical cells. Oncogene 2008; 27:1071-8; PMID:17704805; http://dx.doi.org/10.1038/sj.onc.1210725
40. Stacey SN, Jordan D, Williamson AJ, Brown M, Coote JH, Arrand JR. Leaky scanning is the predominant mechanism for translation of human papillomavirus type 16 E7 oncoprotein from E6/E7 bicistronic mRNA. J Virol 2000; 74:7284-97; PMID:10906182; http://dx.doi.org/10.1128/JVI.74.16.7284-7297.2000
41. Münger K, Basile JR, Duensing S, Eichten A, Gonzalez SL, Grace M, Zacny VL. Biological activities and molecular targets of the human papillomavirus E7 oncoprotein. Oncogene 2001; 20:7888-98; PMID:11753671; http://dx.doi.org/10.1038/sj.onc.1204860
42. Ghittoni R, Accardi R, Hasan U, Gheit T, Sylla B, Tommasino M. The biological properties of E6 and E7 oncoproteins from human papillomaviruses. Virus Genes 2010; 40:1-13; PMID:19838783; http://dx.doi.org/10.1007/s11262-009-0412-8
43. Thomas M, Banks L. Inhibition of Bak-induced apoptosis by HPV-18 E6. Oncogene 1998; 17:2943-54; PMID:9881696; http://dx.doi.org/10.1038/sj.onc.1202223
44. Magal SS, Jackman A, Ish-Shalom S, Botzer LE, Gonen P, Schlegel R, Sherman L. Downregulation of Bax mRNA expression and protein stability by the E6 protein of human papillomavirus 16. J Gen Virol 2005; 86:611-21; PMID:15722521; http://dx.doi.org/10.1099/vir.0.80453-0
45. Thomas M, Laura R, Hepner K, Guccione E, Sawyers C, Lasky L, Banks L. Oncogenic human papillomavirus E6 proteins target the MAGI-2 and MAGI-3 proteins for degradation. Oncogene 2002; 21:5088-96; PMID:12140759; http://dx.doi.org/10.1038/sj.onc.1205668
46. Nguyen ML, Nguyen MM, Lee D, Griep AE, Lambert PF. The PDZ ligand domain of the human papillomavirus type 16 E6 protein is required for E6's induction of epithelial hyperplasia in vivo. J Virol 2003a; 77:6957-64; PMID:12768014; http://dx.doi.org/10.1128/JVI.77.12.6957-6964.2003
47. Nguyen MM, Nguyen ML, Caruana G, Bernstein A, Lambert PF, Griep AE. Requirement of PDZ-containing proteins for cell cycle regulation and differentiation in the mouse lens epithelium. Mol Cell Biol 2003b; 23:8970-81; PMID:14645510; http://dx.doi.org/10.1128/MCB.23.24.8970-8981.2003
48. Yasmeen A, Bismar TA, Kandouz M, Foulkes WD, Desprez PY, Al Moustafa AE. E6/E7 of HPV type 16 promotes cell invasion and metastasis of human breast cancer cells. Cell Cycle 2007; 6:2038-42; PMID:17721085; http://dx.doi.org/10.4161/cc.6.16.4555
49. Szarewski A. HPV vaccine: Cervarix. Expert Opin Biol Ther 2010; 10:477-87; PMID:20132062; http://dx.doi.org/10.1517/14712591003601944
50. Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, Snijders PJ, Peto J, Meijer CJ, Muñoz N. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 1999; 189:12-9; PMID:10451482; http://dx.doi.org/10.1002/(SICI)1096-9896(199909)189:1〈12::AIDPATH431〉3.0.CO;2-F
51. Li N, Franceschi S, Howell-Jones R, Snijders PJ, Clifford GM. Human papillomavirus type distribution in 30,848 invasive cervical cancers worldwide: Variation by geographical region, histological type and year of publication. Int J Cancer 2011; 128:927-35; PMID:20473886; http://dx.doi.org/10.1002/ijc.25396
52. Soost HJ, Lange HJ, Lehmacher W, Ruffing-Kullmann B. The validation of cervical cytology. Sensitivity, specificity and predictive values. Acta Cytol 1991; 35:8-14; PMID:1994641
53. Franco EL. Chapter 13: Primary screening of cervical cancer with human papillomavirus tests. J Natl Cancer Inst Monogr; 2003. p.89-96.
54. Brown DR, Kjaer SK, Sigurdsson K, Iversen OE, Hernandez-Avila M, Wheeler CM, Perez G, Koutsky LA, Tay EH, Garcia P, et al. The impact of quadrivalent human papillomavirus (HPV; types 6, 11, 16, and 18) L1 virus-like particle vaccine on infection and disease due to oncogenic nonvaccine HPV types in generally HPV-naive women aged 16-26 years. J Infect Dis 2009; 199:926-35; PMID:19236279; http://dx.doi.org/10.1086/597307
55. Paavonen J, Naud P, Salmerón J, Wheeler CM, Chow SN, Apter D, Kitchener H, Castellsague X, Teixeira JC, Skinner SR, et al.; HPV PATRICIA Study Group. Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a doubleblind, randomised study in young women. Lancet 2009; 374:301-14; PMID:19586656; http://dx.doi.org/10.1016/S0140-6736(09)61248-4
56. Tota JE, Chevarie-Davis M, Richardson LA, Devries M, Franco EL. Epidemiology and burden of HPV infection and related diseases: implications for prevention strategies. Prev Med 2011; 53(Suppl 1):S12-21; PMID:21962466; http://dx.doi.org/10.1016/j.ypmed.2011.08.017
57. Kane MA, Serrano B, de Sanjosé S, Wittet S. Implementation of human papillomavirus immunization in the developing world. Vaccine 2012; 30(Suppl 5):F192-200; PMID:23199963; http://dx.doi.org/10.1016/j.vaccine.2012.06.075
58. Williams-Brennan L, Gastaldo D, Cole DC, Paszat L. Social determinants of health associated with cervical cancer screening among women living in developing countries: a scoping review. Arch Gynecol Obstet 2012; 286:1487-505; PMID:23011733; http://dx.doi.org/10.1007/s00404-012-2575-0
59. Tsu V, Murray M, Franceschi S. Human papillomavirus vaccination in low-resource countries: lack of evidence to support vaccinating sexually active women. Br J Cancer 2012; 107:1445-50; PMID:22955856; http://dx.doi.org/10.1038/bjc.2012.404
60. Bradford L, Goodman A. Cervical cancer screening and prevention in low-resource settings. Clin Obstet Gynecol 2013; 56:76-87; PMID:23337844; http://dx.doi.org/10.1097/GRF.0b013e31828237ac
61. Hammouda D, Muñoz N, Herrero R, Arslan A, Bouhadef A, Oublil M, Djedeat B, Fontanière B, Snijders P, Meijer C, et al. Cervical carcinoma in Algiers, Algeria: human papillomavirus and lifestyle risk factors. Int J Cancer 2005; 113:483-9; PMID:15455386; http://dx.doi.org/10.1002/ijc.20600
62. Bosch FX, Manos MM, Muñoz N, Sherman M, Jansen AM, Peto J, Schiffman MH, Moreno V, Kurman R, Shah KV. Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) Study Group. J Natl Cancer Inst 1995; 87:796-802; PMID:7791229; http://dx.doi.org/10.1093/jnci/87.11.796
63. Ahmed MI, Salahy EE, Fayed ST, El-Hefnawy NG, Khalifa A. Human papillomavirus infection among Egyptian females with cervical carcinoma: relationship to spontaneous apoptosis and TNF-alpha. Clin Biochem 2001; 34:491-8; PMID:11676979; http://dx.doi.org/10.1016/S0009-9120(01)00243-0
64. Bahnassy AA, Zekri AR, Alam El-Din HM, Aboubakr AA, Kamel K, El-Sabah MT, Mokhtar NM. The role of cyclins and cyclins inhibitors in the multistep process of HPV-associated cervical carcinoma. J Egypt Natl Canc Inst 2006; 18:292-302; PMID:18301453
65. Abd El-Azim S, Lotfy M, Omr A. Detection of human papillomavirus genotypes in cervical intraepithelial neoplasia and invasive cancer patients: Sharkia Governorate, Egypt. Clin Lab 2011; 57:363-71; PMID:21755827
66. Hamkar R, Azad TM, Mahmoodi M, Seyedirashti S, Severini A, Nategh R. Prevalence of human papillomavirus in Mazandaran Province, Islamic Republic of Iran. East Mediterr Health J 2002; 8:805-11; PMID:15568458
67. Mortazavi S, Zali M, Raoufi M, Nadji M, Kowsarian P, Nowroozi A. The Prevalence of Human Papillomavirus in Cervical Cancer in Iran. Asian Pac J Cancer Prev 2002; 3:69-72; PMID:12718611
68. Farjadian S, Asadi E, Doroudchi M, Dehaghani AS, Tabei SZ, Kumar VP, Ghaderi A. High risk HPV types in southern Iranian patients with cervical cancer. Pathol Oncol Res 2003; 9:121-5; PMID:12858218; http://dx.doi.org/10.1007/BF03033756
69. Esmaeili M, Bonyadi M, Dastranj A, Alizadeh M, Melli MS, Shobeiri MJ. HPV typing in women with cervical precancerous and cancerous lesions in northwestern Iran. Gynecol Obstet Invest 2008; 66:68-72; PMID:18500169; http://dx.doi.org/10.1159/000134917
70. Raji N, Sadeghizadeh M, Tafreshi KN, Jahanzad E. Detection of human Papillomavirus 18 in cervical cancer samples using PCR-ELISA (DIAPOPS). Iran J Microbiol 2011; 3:177-82; PMID:22530085
71. Khodakarami N, Clifford GM, Yavari P, Farzaneh F, Salehpour S, Broutet N, Bathija H, Heideman DA, van Kemenade FJ, Meijer CJ, et al. Human papillomavirus infection in women with and without cervical cancer in Tehran, Iran. Int J Cancer 2012; 131:E156-61; PMID:22038830; http://dx.doi.org/10.1002/ijc.26488
72. Shahsiah R, Khademalhosseini M, Mehrdad N, Ramezani F, Nadji SA. Human papillomavirus genotypes in Iranian patients with cervical cancer. Pathol Res Pract 2011; 207:754-7; PMID:22041132; http://dx.doi.org/10.1016/j.prp.2011.09.011
73. Laskov I, Grisaru D, Efrat G, Trejo LL, Grisaru G, Avidor B. Are the human papillomavirus genotypes different in cervical cancer and intraepithelial neoplasia in Jewish Israeli women, a low-risk population? Int J Gynecol Cancer 2013; 23:730-4; PMID:23446379; http://dx.doi.org/10.1097/IGC.0b013e318288eee5
74. Almog B, Gamzu R, Kuperminc MJ, Levin I, Fainaru O, Niv J, Bar-Am A. Human papilloma virus testing in patient follow-up post cone biopsy due to high-grade cervical intraepithelial neoplasia. Gynecol Oncol 2003; 88:345-50; PMID:12648585; http://dx.doi.org/10.1016/S0090-8258(02)00137-3
75. Gamzu R, Almog B, Levin I, Fainaru O, Niv J, Lessing JB, Bar-Am A. Clinical and economic implications of adding HPV tests to the routine cytology follow-up and management of patients with histologically defined cervical intraepithelial neoplasia grade 1. Gynecol Oncol 2002; 86:129-33; PMID:12144817; http://dx.doi.org/10.1006/gyno.2002.6725
76. Menczer J, Fintsi Y, Arbel-Alon S, Tell L, Friedman E, Jackman A, Sherman L. The presence of HPV 16, 18 and p53 immunohistochemical staining in tumor tissue of Israeli Jewish women with cervical and vulvar neoplasia. Eur J Gynaecol Oncol 2000; 21:30-4; PMID:10726615
77. Fait G, Daniel Y, Kupferminc MJ, Lessing JB, Niv J, Bar-Am A. Does typing of human papillomavirus assist in the triage of women with repeated low-grade, cervical cytologic abnormalities? Gynecol Oncol 1998; 70:319-22; PMID:9790781; http://dx.doi.org/10.1006/gyno.1998.5115
78. Isacsohn M, Dolberg L, Sabag SG, Mitrani-Rosenbaum S, Nubani N, Diamant YZ, Goldsmidt R. The inter-relationship of herpes virus, papilloma 16/18 virus infection and Pap smear pathology in Israeli women. Isr J Med Sci 1994; 30:383-7; PMID:8034488
79. Sughayer MA, Abdelhadi M, Abdeen G, Otay L, Dayeh T. Human papillomavirus genotypes in invasive cervical cancer in Jordan. Int J Gynaecol Obstet 2010; 108:74-5; PMID:19892334; http://dx.doi.org/10.1016/j.ijgo.2009.08.025
80. Al-Awadhi R, Chehadeh W, Jaragh M, Al-Shaheen A, Sharma P, Kapila K. Distribution of human papillomavirus among women with abnormal cervical cytology in Kuwait. Diagn Cytopathol 2013; 41:107-14; PMID:21987449; http://dx.doi.org/10.1002/dc.21778
81. Finan RR, Musharrafieh U, Almawi WY. Detection of Chlamydia trachomatis and herpes simplex virus type 1 or 2 in cervical samples in human papilloma virus (HPV)-positive and HPV-negative women. Clin Microbiol Infect 2006; 12:927-30; PMID:16882302; http://dx.doi.org/10.1111/j.1469-0691.2006.01479.x
82. Meftah el khair M, Ait Mhand R, Mzibri ME, Ennaji MM. Risk factors of invasive cervical cancer in Morocco. Cell Mol Biol (Noisy-le-grand) 2009; 55(Suppl):OL1175-85; PMID:20003812
83. Khair MM, Mzibri ME, Mhand RA, Benider A, Benchekroun N, Fahime EM, Benchekroun MN, Ennaji MM. Molecular detection and genotyping of human papillomavirus in cervical carcinoma biopsies in an area of high incidence of cancer from Moroccan women. J Med Virol 2009; 81:678-84; PMID:19235879; http://dx.doi.org/10.1002/jmv.21279
84. Anwar K, Inuzuka M, Shiraishi T, Nakakuki K. Detection of HPV DNA in neoplastic and non-neoplastic cervical specimens from Pakistan and Japan by non-isotopic in situ hybridization. Int J Cancer 1991; 47:675-80; PMID:1848535; http://dx.doi.org/10.1002/ijc.2910470508
85. Khan S, Jaffer NN, Khan MN, Rai MA, Shafiq M, Ali A, Pervez S, Khan N, Aziz A, Ali SH. Human papillomavirus subtype 16 is common in Pakistani women with cervical carcinoma. Int J Infect Dis 2007; 11:313-7; PMID:17291804; http://dx.doi.org/10.1016/j.ijid.2006.06.007
86. Alsbeih G, Al-Harbi N, El-Sebaie M, Al-Badawi I. HPV prevalence and genetic predisposition to cervical cancer in Saudi Arabia. Infect Agent Cancer 2013; 8:15; PMID:23642098; http://dx.doi.org/10.1186/1750-9378-8-15
87. Al-Badawi IA, Al-Suwaine A, Al-Aker M, Asaad L, Alaidan A, Tulbah A, Fe Bohol M, Munkarah AR. Detection and genotyping of human papilloma virus in cervical cancer specimens from Saudi patients. Int J Gynecol Cancer 2011; 21:907-10; PMID:21697680; http://dx.doi.org/10.1097/IGC.0b013e318214219f
88. Abate E, Aseffa A, El-Tayeb M, El-Hassan I, Yamuah L, Mihret W, Bekele L, Ashenafi S, El-Dawi N, Belayneh M, et al. Genotyping of human papillomavirus in paraffin embedded cervical tissue samples from women in Ethiopia and the Sudan. J Med Virol 2013; 85:282-7; PMID:23160919; http://dx.doi.org/10.1002/jmv.23437
89. Eltahir HA, Elhassan AM, Ibrahim ME. Contribution of retinoblastoma LOH and the p53 Arg/Pro polymorphism to cervical cancer. Mol Med Rep 2012; 6:473-6; PMID:22692183
90. Darnel AD, Wang D, Ghabreau L, Yasmeen A, Sami S, Akil N, Al Moustafa AE. Correlation between the presence of high-risk human papillomaviruses and Id gene expression in Syrian women with cervical cancer. Clin Microbiol Infect 2010; 16:262-6; PMID:19438642; http://dx.doi.org/10.1111/j.1469-0691.2009.02774.x
91. Missaoui N, Hmissa S, Frappart L, Trabelsi A, Ben Abdelkader A, Traore C, Mokni M, Yaacoubi MT, Korbi S. p16INK4A overexpression and HPV infection in uterine cervix adenocarcinoma. Virchows Arch 2006; 448:597-603; PMID:16496173; http://dx.doi.org/10.1007/s00428-005-0141-x
92. Missaoui N, Hmissa S, Trabelsi A, Tahar Yacoubi M, Nouira A, Frappart L, Mokni M, Korbi S. [Prevalence of HPV infection in precancerous and cancerous lesions of the uterine cervix in Tunisia]. Ann Biol Clin (Paris) 2010; 68:297-303; http://dx.doi.org/10.1684/abc.2010.0431; PMID:20478773
93. Kasap B, Yetimalar H, Keklik A, Yildiz A, Cukurova K, Soylu F. Prevalence and risk factors for human papillomavirus DNA in cervical cytology. Eur J Obstet Gynecol Reprod Biol 2011; 159:168-71; PMID:21764503; http://dx.doi.org/10.1016/j.ejogrb.2011.06.021
94. Kuyumcuoglu U, Hocaoglu S, Guzel AI, Celik Y. The clinical significance of HPV screening in premalignant cervical lesions. Eur J Gynaecol Oncol 2010; 31:596-7; PMID:21061813
95. Usubütün A, Alemany L, Küc¸ükali T, Ayhan A, Yüce K, de Sanjosé S, Font R, Lloveras B, Klaustermeier J, Quint W, et al. Human papillomavirus types in invasive cervical cancer specimens from Turkey. Int J Gynecol Pathol 2009; 28:541-8; PMID:19851201; http://dx.doi.org/10.1097/PGP.0b013e3181aaba0d
96. Dane C, Batmaz G, Dane B, Cetin A. Screening properties of human papillomavirus testing for predicting cervical intraepithelial neoplasia in atypical squamous cells of undetermined significance and low-grade squamous intraepithelial lesion smears: a prospective study. Ann Diagn Pathol 2009; 13:73-7; PMID:19302953; http://dx.doi.org/10.1016/j.anndiagpath.2008.12.001
97. Cirpan T, Guliyeva A, Onder G, Terek MC, Ozsaran A, Kabasakal Y, Zekioglu O, Yucebilgin S. Comparison of human papillomavirus testing and cervical cytology with colposcopic examination and biopsy in cervical cancer screening in a cohort of patients with Sjogren's syndrome. Eur J Gynaecol Oncol 2007; 28:302-6; PMID:17713098
98. Myers EN, Suen JY. Cancer of the Head and Neck, 4th ed., Philadelphia, London: WB Saunder; 2003.
99. Dhooge IJ, De Vos M, Van Cauwenberge PB. Multiple primary malignant tumors in patients with head and neck cancer: results of a prospective study and future perspectives. Laryngoscope 1998; 108:250-6; PMID:9473077; http://dx.doi.org/10.1097/00005537-199802000-00017
100. de Bree R, Deurloo EE, Snow GB, Leemans CR. Screening for distant metastases in patients with head and neck cancer. Laryngoscope 2000; 110:397-401; PMID:10718426; http://dx.doi.org/10.1097/00005537-200003000-00012
101. Forastiere A, Koch W, Trotti A, Sidransky D. Head and neck cancer. N Engl J Med 2001; 345:1890-900; PMID:11756581; http://dx.doi.org/10.1056/NEJMra001375
102. Bjordal K, Ahlner-Elmqvist M, Hammerlid E, Boysen M, Evensen JF, Biörklund A, Jannert M, Westin T, Kaasa S. A prospective study of quality of life in head and neck cancer patients. Part II: Longitudinal data. Laryngoscope 2001; 111:1440-52; PMID:11568582; http://dx.doi.org/10.1097/00005537-200108000-00022
103. Al Moustafa AE, Alaoui-Jamali MA, Batist G, Hernandez-Perez M, Serruya C, Alpert L, Black MJ, Sladek R, Foulkes WD. Identification of genes associated with head and neck carcinogenesis by cDNA microarray comparison between matched primary normal epithelial and squamous carcinoma cells. Oncogene 2002; 21:2634-40; PMID:11965536; http://dx.doi.org/10.1038/sj.onc.1205351
104. Goldenberg D, Lee J, Koch WM, Kim MM, Trink B, Sidransky D, Moon CS. Habitual risk factors for head and neck cancer. Otolaryngol Head Neck Surg 2004; 131:986-93; PMID:15577802; http://dx.doi.org/10.1016/j.otohns.2004.02.035
105. Goldenberg D, Golz A, Joachims HZ. The beverage maté: a risk factor for cancer of the head and neck. Head Neck 2003; 25:595-601; PMID:12808663; http://dx.doi.org/10.1002/hed.10288
106. Löning T, Meichsner M, Milde-Langosch K, Hinze H, Orlt I, Hörmann K, Sesterhenn K, Becker J, Reichart P. HPV DNA detection in tumours of the head and neck: a comparative light microscopy and DNA hybridization study. ORL J Otorhinolaryngol Relat Spec 1987; 49:259-69; PMID:2823203; http://dx.doi.org/10.1159/000275948
107. McKaig RG, Baric RS, Olshan AF. Human papillomavirus and head and neck cancer: epidemiology and molecular biology. Head Neck 1998; 20:250-65; PMID:9570632; http://dx.doi.org/10.1002/(SICI)1097-0347(199805)20:3〈250::AIDHED11〉3.0.CO;2-O
108. O'Rorke MA, Ellison MV, Murray LJ, Moran M, James J, Anderson LA. Human papillomavirus related head and neck cancer survival: a systematic review and meta-analysis. Oral Oncol 2012; 48:1191-201; PMID:22841677; http://dx.doi.org/10.1016/j.oraloncology.2012.06.019
109. Hafed L, Farag H, Shaker O, El-Rouby D. Is human papilloma virus associated with salivary gland neoplasms? An in situ-hybridization study. Arch Oral Biol 2012; 57:1194-9; PMID:22542162; http://dx.doi.org/10.1016/j.archoralbio.2012.03.009
110. Mansour A, Ali M, Helmy H, Kassim S. Human papillomavirus-16 (HPV-16) infection association with CIAP-2 expression in head and neck cancer. Med Oncol 2012; 29:2459-65; PMID:22215414; http://dx.doi.org/10.1007/s12032-011-0143-2
111. Mirzamani N, Salehian P, Farhadi M, Tehran EA. Detection of EBV and HPV in nasopharyngeal carcinoma by in situ hybridization. Exp Mol Pathol 2006; 81:231-4; PMID:16787643; http://dx.doi.org/10.1016/j.yexmp.2006.04.006
112. SahebJamee M, Boorghani M, Ghaffari SR, AtarbashiMoghadam F, Keyhani A. Human papillomavirus in saliva of patients with oral squamous cell carcinoma. Med Oral Patol Oral Cir Bucal 2009; 14:e525-8; PMID:19680210; http://dx.doi.org/10.4317/medoral.14.e525
113. Saghravanian N, Ghazvini K, Babakoohi S, Firooz A, Mohtasham N. Low prevalence of high risk genotypes of human papilloma virus in normal oral mucosa, oral leukoplakia and verrucous carcinoma. Acta Odontol Scand 2011; 69:406-9; PMID:21466259; http://dx.doi.org/10.3109/00016357.2011.572560
114. Seraj JM, Yazdani N, Ashtiani ZO, Seraj SM, Hasheminasab SM, Memar B, Mirashrafi F, Borghei H, Yazdani J, Mostaan LV. TP53 gene expression in HPV-positive oral tongue SCC and its correlation with nodal metastasis. Pathol Res Pract 2011; 207:758-61; PMID:22055991; http://dx.doi.org/10.1016/j.prp.2011.09.013
115. Falaki F, Dalirsani Z, Pakfetrat A, Falaki A, Saghravanian N, Nosratzehi T, Pazouki M. Clinical and histopathological analysis of oral squamous cell carcinoma of young patients in Mashhad, Iran: a retrospective study and review of literature. Med Oral Patol Oral Cir Bucal 2011; 16:e473-7; PMID:20711159; http://dx.doi.org/10.4317/medoral.16.e473
116. Niv A, Sion-Vardi N, Gatot A, Nash M, Fliss DM. Identification and typing of human papillomavirus (HPV) in squamous cell carcinoma of the oral cavity and oropharynx. J Laryngol Otol 2000; 114:41-6; PMID:10789410; http://dx.doi.org/10.1258/0022215001903870
117. Baig S, Lucky MH, Qamar A, Ahmad F, Khan S, Ahmed W, Chughtai T, Hassan W, Hussain BA, Khan A. Human papilloma virus and oral lesions in gutka eating subjects in Karachi. J Coll Physicians Surg Pak 2012; 22:135-8; PMID:22414350
118. Ahmed S, Jafarey NA. Association of herpes simplex virus type-I and human papilloma virus with carcinoma of the oral cavity and oropharynx. J Environ Pathol Toxicol Oncol 1995; 14:193-6; PMID:9003697
119. Jalouli J, Jalouli MM, Sapkota D, Ibrahim SO, Larsson PA, Sand L. Human papilloma virus, herpes simplex virus and epstein barr virus in oral squamous cell carcinoma from eight different countries. Anticancer Res 2012; 32:571-80; PMID:22287747
120. Jalouli J, Ibrahim SO, Sapkota D, Jalouli MM, Vasstrand EN, Hirsch JM, et al. Presence of human papilloma virus, herpes simplex virus and Epstein-Barr virus DNA in oral biopsies from Sudanese patients with regard to toombak use. J Oral Pathol Med. 2010;39:599-604
121. Ahmed HG, Mustafa SA, Warille E. Human papilloma virus attributable head and neck cancer in the sudan assessed by p16INK4A immunostaining. Asian Pac J Cancer Prev 2012; 13:6083-6; PMID:23464408; http://dx.doi.org/10.7314/APJCP.2012.13.12.6083
122. Ibrahim SO, Bertelsen B, Kalvenes MB, Idris AM, Vasstrand EN, Nilsen R, Johannessen AC. Expression of keratin 13, 14 and 19 in oral squamous cell carcinomas from Sudanese snuff dippers: lack of association with human papillomavirus infection. APMIS 1998; 106:959-69; PMID:9833698; http://dx.doi.org/10.1111/j.1699-0463.1998.tb00246.x
123. Kaya H, Kotiloʇlu E, Inanli S, Ekicioʇlu G, Bozkurt SU, Tutkun A, Küllü S. Prevalence of human papillomavirus (HPV) DNA in larynx and lung carcinomas. Pathologica 2001; 93:531-4; PMID:11725354
124. Güvenc¸ MG, Midilli K, Ozdoʇan A, Inci E, Tahamiler R, Enver O, Sirin G, Ergin S, Kuşkucu M, Divanoʇlu EO, et al. Detection of HHV-8 and HPV in laryngeal carcinoma. Auris Nasus Larynx 2008; 35:357-62; PMID:17977679; http://dx.doi.org/10.1016/j.anl.2007.08.006
125. Bozdayi G, Kemaloglu Y, Ekinci O, Dogan B, Ilhan MN, Aydil U, Akyol G, Koybasioglu A, Inal E, Rota S. Role of human papillomavirus in the clinical and histopathologic features of laryngeal and hypopharyngeal cancers. J Otolaryngol Head Neck Surg 2009; 38:119-25; PMID:19344621
126. Kingham TP, Pachter HL. Colonic anastomotic leak: risk factors, diagnosis, and treatment. J Am Coll Surg 2009; 208:269-78; PMID:19228539; http://dx.doi.org/10.1016/j.jamcollsurg.2008.10.015
127. de Sanjosé S, Diaz M, Castellsagué X, Clifford G, Bruni L, Muñoz N, Bosch FX. Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: a meta-analysis. Lancet Infect Dis 2007; 7:453-9; PMID:17597569; http://dx.doi.org/10.1016/S1473-3099(07)70158-5
128. Abramowitz L, Jacquard AC, Jaroud F, Haesebaert J, Siproudhis L, Pradat P, Aynaud O, Leocmach Y, Soubeyrand B, Dachez R, et al. Human papillomavirus genotype distribution in anal cancer in France: the EDiTH V study. Int J Cancer 2011; 129:433-9; PMID:20839262; http://dx.doi.org/10.1002/ijc.25671
129. Shukla S, Bharti AC, Mahata S, Hussain S, Kumar R, Hedau S, Das BC. Infection of human papillomaviruses in cancers of different human organ sites. Indian J Med Res 2009; 130:222-33; PMID:19901431
130. Gornick MC, Castellsague X, Sanchez G, Giordano TJ, Vinco M, Greenson JK, Capella G, Raskin L, Rennert G, Gruber SB, et al. Human papillomavirus is not associated with colorectal cancer in a large international study. Cancer Causes Control 2010; 21:737-43; PMID:20087645; http://dx.doi.org/10.1007/s10552-010-9502-0
131. Oh SY, Kim YB, Suh KW, Paek OJ, Moon HY. Prognostic impact of fascin-1 expression is more significant in advanced colorectal cancer. J Surg Res 2012; 172:102-8; PMID:20851411; http://dx.doi.org/10.1016/j.jss.2010.07.015
132. Ling MT, Wang X, Zhang X, Wong YC. The multiple roles of Id-1 in cancer progression. Differentiation 2006; 74:481-7; PMID:17177845; http://dx.doi.org/10.1111/j.1432-0436.2006.00083.x
133. Van Marck V, Stove C, Jacobs K, Van den Eynden G, Bracke M. P-cadherin in adhesion and invasion: opposite roles in colon and bladder carcinoma. Int J Cancer 2011; 128:1031-44; PMID:20473917; http://dx.doi.org/10.1002/ijc.25427
134. Ghabreau L, Segal ED, Yasmeen A, Kassab A, Akil N, Al Moustafa AE. High-risk human papillomavirus infections in colorectal cancer in the Syrian population and their association with Fascin, Id-1 and P-cadherin expressions: A tissue microarray study. Clin Cancer Investig J 2012; 1:26-30; http://dx.doi.org/10.4103/2278-0513.95016
135. Ricciardi R, Ghabreau L, Yasmeen A, Darnel AD, Akil N, Al Moustafa AE. Role of E6/E7 onco-proteins of high-risk human papillomaviruses in human colorectal carcinogenesis. Cell Cycle 2009; 8:1964-5; PMID:19411835; http://dx.doi.org/10.4161/cc.8.12.8618
136. Salepci T, Yazici H, Dane F, Topuz E, Dalay N, Onat H, Aykan F, Seker M, Aydiner A. Detection of human papillomavirus DNA by polymerase chain reaction and southern blot hybridization in colorectal cancer patients. J BUON 2009; 14:495-9; PMID:19810144
137. Buyru N, Tezol A, Dalay N. Coexistence of K-ras mutations and HPV infection in colon cancer. BMC Cancer 2006; 6:115; PMID:16672071; http://dx.doi.org/10.1186/1471-2407-6-115
138. Yavuzer D, Karadayi N, Salepci T, Baloglu H, Dabak R, Bayramicli OU. Investigation of human papillomavirus DNA in colorectal carcinomas and adenomas. Med Oncol 2011; 28:127-32; PMID:20082157; http://dx.doi.org/10.1007/s12032-010-9416-4
139. Kroupis C, Markou A, Vourlidis N, Dionyssiou-Asteriou A, Lianidou ES. Presence of highrisk human papillomavirus sequences in breast cancer tissues and association with histopathological characteristics. Clin Biochem 2006; 39:727-31; PMID:16780823; http://dx.doi.org/10.1016/j.clinbiochem.2006.03.005
140. Gumus M, Yumuk PF, Salepci T, Aliustaoglu M, Dane F, Ekenel M, Basaran G, Kaya H, Barisik N, Turhal NS. HPV DNA frequency and subset analysis in human breast cancer patients' normal and tumoral tissue samples. J Exp Clin Cancer Res 2006; 25:515-21; PMID:17310842
141. Simões PW, Medeiros LR, Simões Pires PD, Edelweiss MI, Rosa DD, Silva FR, Silva BR, Rosa MI. Prevalence of human papillomavirus in breast cancer: a systematic review. Int J Gynecol Cancer 2012; 22:343-7; PMID:22214962; http://dx.doi.org/10.1097/IGC.0b013e31823c712e
142. Li N, Bi X, Zhang Y, Zhao P, Zheng T, Dai M. Human papillomavirus infection and sporadic breast carcinoma risk: a meta-analysis. Breast Cancer Res Treat 2011; 126:515-20; PMID:20740311; http://dx.doi.org/10.1007/s10549-010-1128-0
143. Deligeoroglou E, Giannouli A, Athanasopoulos N, Karountzos V, Vatopoulou A, Dimopoulos K, Creatsas G. HPV infection: immunological aspects and their utility in future therapy. Infect Dis Obstet Gynecol 2013; 2013:540850; PMID:24023507; http://dx.doi.org/10.1155/2013/540850
144. Scheurer ME, Tortolero-Luna G, Adler-Storthz K. Human papillomavirus infection: biology, epidemiology, and prevention. Int J Gynecol Cancer 2005; 15:727-46; PMID:16174218; http://dx.doi.org/10.1111/j.1525-1438.2005.00246.x
145. Roldão A, Mellado MC, Castilho LR, Carrondo MJ, Alves PM. Virus-like particles in vaccine development. Expert Rev Vaccines 2010; 9:1149-76; PMID:20923267; http://dx.doi.org/10.1586/erv.10.115
146. Kwak K, Yemelyanova A, Roden RB. Prevention of cancer by prophylactic human papillomavirus vaccines. Curr Opin Immunol 2011; 23:244-51; PMID:21185706; http://dx.doi.org/10.1016/j.coi.2010.11.009
147. Kawana K, Yasugi T, Taketani Y. Human papillomavirus vaccines: current issues & future. Indian J Med Res 2009; 130:341-7; PMID:19901444
148. Al Moustafa AE, Yasmeen A, Ghabreau L, Akil N. Does the Syrian population have to wait for the new generation of human papillomaviruses vaccine? Hum Vaccin Immunother 2012; 8:1867-8; PMID:23032164; http://dx.doi.org/10.4161/hv.21973
149. Bharadwaj M, Hussain S, Nasare V, Das BC. HPV & HPV vaccination: issues in developing countries. Indian J Med Res 2009; 130:327-33; PMID:19901442
150. Ortashi O, Raheel H, Khamis J. Acceptability of human papillomavirus vaccination among male university students in the United Arab Emirates. Vaccine 2013; 31:5141-4; PMID:23965182; http://dx.doi.org/10.1016/j.vaccine.2013.08.016
151. Ortashi O, Shallal M, Osman N, Raheel H. Knowledge, attitude and practice of school nurses in the United Arab Emirates about HPV infection and vaccine. Asian Pac J Cancer Prev 2012; 13:6481-4; PMID:23464478; http://dx.doi.org/10.7314/APJCP.2012.13.12.6481
152. Serrano B, Alemany L, Tous S, Bruni L, Clifford GM, Weiss T, Bosch FX, de Sanjosé S. Potential impact of a nine-valent vaccine in human papillomavirus related cervical disease. Infect Agent Cancer 2012; 7:38; PMID:23273245; http://dx.doi.org/10.1186/1750-9378-7-38